Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

gilead sciences ireland uc, galapagos nv - filgotinib maleate - artritas, reumatas - imunosupresantai - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

eli lilly nederland b.v. - baricitinib - artritas, reumatas - imunosupresantai - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumianetą galima vartoti kaip monoterapiją arba kartu su metotreksatu. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

merck europe b.v. - cladribine - išsėtinė sklerozė - imunosupresantai - suaugusių pacientų su labai aktyvaus recidyvuojančia išsėtine skleroze (is) nustatytus klinikinių ar vizualizavimo įranga.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

merck sharp & dohme b.v. - gyvas susilpnintas vėjaraupių virusas (oka/merck padermės) - milteliai ir tirpiklis injekcinei suspensijai užpildytame švirkšte - 1350 pfv/dozėje - varicella, live attenuated

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

mra, uab - trazodonas - pailginto atpalaidavimo tabletės - 75 mg; 150 mg - trazodone

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

aspen pharma trading limited - azatioprinas - plėvele dengtos tabletės - 50 mg - azathioprine

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

accord healthcare b.v. - acikloviras - koncentratas infuziniam tirpalui - 25 mg/ml - aciclovir

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

sanofi winthrop industrie - isatuximab - daugybinė mieloma - antinavikiniai vaistai - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - talidomidas - daugybinė mieloma - imunosupresantai - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy. thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

egis pharmaceuticals plc - glicerolio trinitratas - poliežuvinis purškalas - 400 µg/išpurškime; 2,6 mg - glyceryl trinitrate